iSTAR Medical SA Sustainability Profile
iSTAR Medical SA, headquartered in Belgium, is a pioneering company in the ophthalmic medical device industry, specialising in innovative solutions for glaucoma treatment. Founded in 2010, iSTAR Medical has made significant strides with its flagship product, the MINIject, a minimally invasive implant designed to lower intraocular pressure effectively. The company operates primarily in Europe and has expanded its reach to various international markets, establishing a strong presence in the ophthalmology sector. iSTAR Medical is recognised for its commitment to advancing patient care through unique, evidence-based technologies that enhance surgical outcomes. With a focus on innovation and quality, iSTAR Medical continues to solidify its position as a leader in the field, contributing to improved treatment options for glaucoma patients worldwide.
DitchCarbon Score
How does iSTAR Medical SA's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
iSTAR Medical SA's score of 26 is lower than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
iSTAR Medical SA's reported carbon emissions
iSTAR Medical SA, headquartered in Belgium, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that iSTAR Medical SA may still be in the early stages of developing its climate commitments or reporting framework. As the company operates within the medical technology sector, it is essential for iSTAR Medical SA to consider establishing clear sustainability goals and emissions reduction strategies in line with industry standards. This could include setting Science-Based Targets (SBTi) or participating in initiatives such as the Carbon Disclosure Project (CDP) to enhance transparency and accountability regarding their environmental impact. In summary, while iSTAR Medical SA has not yet disclosed any emissions data or climate commitments, there is an opportunity for the company to engage in meaningful climate action and reporting in the future.
How Carbon Intensive is iSTAR Medical SA's Industry?
How Carbon Intensive is iSTAR Medical SA's Location?
iSTAR Medical SA's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
iSTAR Medical SA has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
